Eric Wooltorton. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adverse Drug Reaction Reporting SystemsAgedAlzheimer Disease/drug therapyAlzheimer Disease/psychologyAntipsychotic Agents/adverse effectsBenzodiazepines/adverse effectsCerebrovascular Disorders/chemically inducedClinical Trials as TopicContraindicationsHumansOlanzapineProduct Surveillance, Postmarketing
Substances: See more » Antipsychotic AgentsBenzodiazepinesOlanzapine
Year: 2004 PMID: 15111472 PMCID: PMC395813 DOI: 10.1503/cmaj.1040539
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262